loadpatents
Patent applications and USPTO patent grants for Harasym; Troy.The latest application filed is for "compositions for delivery of drug combinations".
Patent | Date |
---|---|
Compositions for delivery of drug combinations Grant 10,722,464 - Tardi , et al. | 2020-07-28 |
Compositions For Delivery Of Drug Combinations App 20180338917 - TARDI; Paul ;   et al. | 2018-11-29 |
Compositions for delivery of drug combinations Grant 10,058,507 - Tardi , et al. August 28, 2 | 2018-08-28 |
Compositions For Delivery Of Drug Combinations App 20160113871 - Tardi; Paul ;   et al. | 2016-04-28 |
Compositions for delivery of drug combinations Grant 9,271,931 - Tardi , et al. March 1, 2 | 2016-03-01 |
Liposomal formulations of anthracycline agents and cytidine analogs Grant 8,431,806 - Mayer , et al. April 30, 2 | 2013-04-30 |
High Efficiency Encapsulation Of Charged Therapeutic Agents In Lipid Vesicles App 20120114831 - Semple; Sean C. ;   et al. | 2012-05-10 |
Liposomal Formulations Of Anthracycline Agents And Cytidine Analogs App 20120009252 - MAYER; Lawrence ;   et al. | 2012-01-12 |
Liposomal formulations of anthracycline agents and cytidine analogs Grant 8,022,279 - Mayer , et al. September 20, 2 | 2011-09-20 |
Lipid-encapsulated polyanionic nucleic acid Grant 8,021,686 - Semple , et al. September 20, 2 | 2011-09-20 |
Compositions for delivery of drug combinations Grant 7,850,990 - Tardi , et al. December 14, 2 | 2010-12-14 |
Combination Formulations Of Cytidine Analogs And Platinum Agents App 20090074848 - Johnstone; Sharon ;   et al. | 2009-03-19 |
High Efficiency Encapsulation Of Charged Therapeutic Agents In Lipid Vesicles App 20080200417 - Semple; Sean C. ;   et al. | 2008-08-21 |
Compositions For Delivery Of Drug Combinations App 20080075762 - Tardi; Paul ;   et al. | 2008-03-27 |
Lipid-encapsulated polyanionic nucleic acid Grant 7,341,738 - Semple , et al. March 11, 2 | 2008-03-11 |
Compositions for Delivery of Drug Combinations App 20070298092 - Tardi; Paul ;   et al. | 2007-12-27 |
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs App 20070286897 - Mayer; Lawrence ;   et al. | 2007-12-13 |
Compositions for delivery of drug combinations App 20070148255 - Tardi; Paul ;   et al. | 2007-06-28 |
Compositions for treating drug resistance App 20060216341 - Tardi; Paul ;   et al. | 2006-09-28 |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles App 20050255153 - Semple, Sean C. ;   et al. | 2005-11-17 |
Lipid-encapsulated polyanionic nucleic acid Grant 6,858,225 - Semple , et al. February 22, 2 | 2005-02-22 |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles App 20050008689 - Semple, Sean C. ;   et al. | 2005-01-13 |
Compositions for delivery of drug combinations App 20040022817 - Tardi, Paul ;   et al. | 2004-02-05 |
Compositions for delivery of drug combinations App 20030147945 - Tardi, Paul ;   et al. | 2003-08-07 |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles App 20030129221 - Semple, Sean C. ;   et al. | 2003-07-10 |
Charged therapeutic agents encapsulated in lipid particles containing four lipid components Grant 6,287,591 - Semple , et al. September 11, 2 | 2001-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.